$2 Million dollar grant to develop first in class cancer therapeutics by NĒRx Biosciences | Aug 9, 2024 | NewsNĒRx will further develop small molecule inhibitors that target the DNA Damage Response pathway for difficult-to-treat cancers, such as lung and ovarian cancer. Read the Article...
